Mostra el registre parcial de l'element

dc.contributorUniversitat Ramon Llull. IQS
dc.contributor.authorPuigmal, Núria
dc.contributor.authorRamos, Víctor
dc.contributor.authorArtzi, Natalie
dc.contributor.authorBorrós i Gómez, Salvador
dc.date.accessioned2024-12-20T08:44:21Z
dc.date.available2024-12-20T08:44:21Z
dc.date.issued2023-04
dc.identifier.issn1999-4923ca
dc.identifier.urihttp://hdl.handle.net/20.500.14342/4659
dc.description.abstractNucleic acid vaccines have become a transformative technology to fight emerging infectious diseases and cancer. Delivery of such via the transdermal route could boost their efficacy given the complex immune cell reservoir present in the skin that is capable of engendering robust immune responses. We have generated a novel library of vectors derived from poly(β-amino ester)s (PBAEs) including oligopeptide-termini and a natural ligand, mannose, for targeted transfection of antigen presenting cells (APCs) such as Langerhans cells and macrophages in the dermal milieu. Our results reaffirmed terminal decoration of PBAEs with oligopeptide chains as a powerful tool to induce cell-specific transfection, identifying an outstanding candidate with a ten-fold increased transfection efficiency over commercial controls in vitro. The inclusion of mannose in the PBAE backbone rendered an additive effect and increased transfection levels, achieving superior gene expression in human monocyte-derived dendritic cells and other accessory antigen presenting cells. Moreover, top performing candidates were capable of mediating surface gene transfer when deposited as polyelectrolyte films onto transdermal devices such as microneedles, offering alternatives to conventional hypodermic administration. We predict that the use of highly efficient delivery vectors derived from PBAEs could advance clinical translation of nucleic acid vaccination over protein- and peptide-based strategies.ca
dc.format.extentp.17ca
dc.language.isoengca
dc.publisherMDPIca
dc.relation.ispartofPharmaceutics 2023, 15(4), 1262ca
dc.rights© L'autor/aca
dc.rightsAttribution 4.0 Internationalca
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.otherPoly(β-amino ester)sca
dc.subject.otherTargeted deliveryca
dc.subject.otherMannoseca
dc.subject.otherTransdermal vaccinationca
dc.subject.otherPlasmid DNAca
dc.subject.otherPolímersca
dc.subject.otherMedicaments--Modes d'administracióca
dc.subject.otherMedicació transdèrmicaca
dc.subject.otherPlasmidisca
dc.titlePoly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccinationca
dc.typeinfo:eu-repo/semantics/articleca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc577ca
dc.subject.udc615ca
dc.identifier.doihttps://doi.org/10.3390/pharmaceutics15041262ca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca


Fitxers en aquest element

 

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

© L'autor/a
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by/4.0/
Comparteix a TwitterComparteix a LinkedinComparteix a FacebookComparteix a TelegramComparteix a WhatsappImprimeix